Emerging Respiratory Pathogen Award Grant

The Emerging Respiratory Pathogen Award, offered by the American Lung Association, aims to enhance our understanding of respiratory infections' pathobiology and their implications. This award supports innovative research addressing the biology of respiratory viruses, host response factors, community spread dynamics of COVID-19, and long-term effects of viral infections. With a funding of $100,000 per year for two years, this initiative encourages groundbreaking studies to improve lung health and disease outcomes.

The Emerging Respiratory Pathogen Award was created to gain a better understanding of the pathobiology and the long term and immediate implications of respiratory infections. The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions:
A new understanding of the basic biology of respiratory viruses that could lead to better treatment and preventionUnderstanding host factors that alter response to these infectionsUnderstanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory virusesCase tracking and epidemiological approaches to understanding COVID-19 and other emerging respiratory virusesThe pathophysiology of the long term sequalae of respiratory viral infections, including COVID-19Key takeaways and lessons learned from the COVID-19 pandemic
The Emerging Respiratory Pathogen Award if for $100,000 per year for two years.